Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Capsaicinoids

PhytochemicalAlkaloidBest with a meal

Capsaicinoids are the pungent vanilloids in chili peppers — capsaicin and dihydrocapsaicin account for most of the activity. They have a split clinical identity: TOPICAL capsaicin is a Cochrane-supported chronic-pain treatment (postherpetic neuralgia, peripheral neuropathy, osteoarthritis). ORAL capsaicinoid supplements (often as 'non-pungent' encapsulated extracts like Capsimax) modestly reduce energy intake and increase thermogenesis — small net effect (~50 kcal/day).

Quick decision guide

May help most

Topical use: adults with localized chronic neuropathic pain or osteoarthritis seeking a non-systemic adjunct. Oral use: adults wanting a modest appetite/thermogenesis bump as part of broader weight-management strategies.

Common dosing range

TOPICAL: 0.025–0.075% cream applied 3–4×/day for 6+ weeks; 8% patch is a clinic procedure (single 30–60 min application provides weeks–months of relief). ORAL: 2–10 mg total capsaicinoids/day, often as encapsulated non-pungent extracts taken 30–60 min before meals.

When to expect effects

Topical: 2–6 weeks for steady-state pain reduction (cream); single application for 8% patch. Oral metabolic effects: per-meal energy-intake reduction within hours; cumulative weight effects modest over weeks.

Watch out for

Topical burn / sting (universal — improves with repeated use); avoid mucous membranes and eyes. Oral: GI burn, heartburn, lower-GI burn at high doses or in those with hemorrhoids/anal fissures.

Evidence snapshot

Topical neuropathic pain (postherpetic / DPN / HIV)Strong (8% patch)

Topical osteoarthritis painModerate

Oral energy intake / thermogenesisEmerging

Oral cardiovascular biomarkersLow

Gastric health (oral, mixed signal)Low

What is it

Capsaicinoids are a family of pungent compounds in Capsicum species (chili peppers), with capsaicin and dihydrocapsaicin being the most abundant; they produce the burning sensation of spicy food.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have postherpetic neuralgia, diabetic peripheral neuropathy, or painful HIV neuropathy — 8% capsaicin patch (clinic procedure) has Cochrane-supported relief

You have localized osteoarthritis pain and want a low-systemic-risk topical adjunct to oral analgesics

You want a modest pre-meal appetite-curbing bump and tolerate spicy food or non-pungent encapsulated capsaicinoids

You're already adding chili regularly to your diet — adding more isn't likely to harm

Probably skip if…

You expect a capsaicinoid pill to cause meaningful weight loss alone — net effect is ~50 kcal/day

You have active gastric or duodenal ulcers — high-dose oral capsaicinoids are not recommended

You have severe hemorrhoids, anal fissures, or IBD flares — lower-GI burn from passed capsaicin is real

You can't tolerate the initial burning of topical capsaicin — desensitisation takes 1–2 weeks of consistent use

You want to apply topical capsaicin near the eyes, on broken skin, or on mucous membranes — never do this

Evidence at a glance

Goal	Effect	Best fit	Time
Topical pain — postherpetic neuralgia / peripheral neuropathy (8% patch) Strong Evidence	NNT ≈10–12 for ≥30% pain relief at 8–12 weeks; single application gives 2–3 months of relief	Adults with postherpetic neuralgia, painful peripheral diabetic neuropathy, painful HIV-associated neuropathy, localised neuropathic pain	2–6 weeks for steady-state effect of low-concentration creams; single 8% patch application gives effect within days
Topical osteoarthritis pain (adjunct) Good Evidence	1–2 point reduction on 10-point pain scale at 4–6 weeks; lower-quality evidence than topical NSAIDs	Adults with knee or hand osteoarthritis seeking a non-systemic topical option	4–6 weeks of consistent daily use
Oral capsaicinoids — energy intake, thermogenesis, weight Limited Evidence	≈74 kcal reduction in subsequent meal energy intake; ≈50 kcal/day thermogenic effect; modest cumulative weight outcome	Adults using oral capsaicinoids as a modest adjunct to broader weight-management efforts	Per-meal effects within hours; cumulative weight outcomes over weeks at best
Cardiovascular biomarkers (oral) Mixed Evidence	Inconsistent small effects on BP and lipids; no hard-endpoint data	Adults using capsaicinoids for other reasons who might get a small cardiovascular nudge	Not reliably established
Functional dyspepsia / gastric tolerance Mixed Evidence	Inconsistent — some patients improve, others worsen	None established	Not reliably established

Topical pain — postherpetic neuralgia / peripheral neuropathy (8% patch)

Strong Evidence

Effect: NNT ≈10–12 for ≥30% pain relief at 8–12 weeks; single application gives 2–3 months of relief
Best fit: Adults with postherpetic neuralgia, painful peripheral diabetic neuropathy, painful HIV-associated neuropathy, localised neuropathic pain
Time: 2–6 weeks for steady-state effect of low-concentration creams; single 8% patch application gives effect within days

Topical osteoarthritis pain (adjunct)

Good Evidence

Effect: 1–2 point reduction on 10-point pain scale at 4–6 weeks; lower-quality evidence than topical NSAIDs
Best fit: Adults with knee or hand osteoarthritis seeking a non-systemic topical option
Time: 4–6 weeks of consistent daily use

Oral capsaicinoids — energy intake, thermogenesis, weight

Limited Evidence

Effect: ≈74 kcal reduction in subsequent meal energy intake; ≈50 kcal/day thermogenic effect; modest cumulative weight outcome
Best fit: Adults using oral capsaicinoids as a modest adjunct to broader weight-management efforts
Time: Per-meal effects within hours; cumulative weight outcomes over weeks at best

Cardiovascular biomarkers (oral)

Mixed Evidence

Effect: Inconsistent small effects on BP and lipids; no hard-endpoint data
Best fit: Adults using capsaicinoids for other reasons who might get a small cardiovascular nudge
Time: Not reliably established

Functional dyspepsia / gastric tolerance

Mixed Evidence

Effect: Inconsistent — some patients improve, others worsen
Best fit: None established
Time: Not reliably established

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Topical pain — postherpetic neuralgia / peripheral neuropathy (8% patch)

Disease adjunct

Strong Evidence

Mou 2013 Cochrane review pooled 8 RCTs of high-concentration topical capsaicin (8% patch, single 30–60-min clinic application) in chronic neuropathic pain: postherpetic neuralgia and painful HIV-associated neuropathy. NNT for ≥30% pain relief at 8–12 weeks was approximately 10–12. Mechanism: TRPV1-mediated reversible defunctionalisation of small-fibre nociceptors. A single application provides weeks to months of relief; repeated applications every 3 months are common. Lower-strength creams (0.025–0.075%) also work for neuropathic pain but require multiple daily applications for 6+ weeks before steady-state effect.

Effect size

NNT ≈10–12 for ≥30% pain relief at 8–12 weeks; single application gives 2–3 months of relief

Time to effect

2–6 weeks for steady-state effect of low-concentration creams; single 8% patch application gives effect within days

Best fit

Adults with postherpetic neuralgia, painful peripheral diabetic neuropathy, painful HIV-associated neuropathy, localised neuropathic pain

Less likely

Adults with diffuse central pain syndromes; people unable to tolerate the initial burning sensation

Bottom line: Genuine, Cochrane-supported topical pain treatment with a strong mechanism story.

SourceMou et al., 2013 (Cochrane) — PubMed — Cochrane Database of Systematic Reviews

Topical osteoarthritis pain (adjunct)

Disease adjunct

Good Evidence

Topical capsaicin 0.025% applied 4×/day modestly reduces pain in knee and hand osteoarthritis. American College of Rheumatology guidelines list topical capsaicin as a conditional recommendation for knee OA. Effect is moderate, not dramatic — typically a 1–2 point reduction on a 10-point pain scale after 4–6 weeks of consistent use. Local burning is the main side effect and improves with continued use.

Effect size

1–2 point reduction on 10-point pain scale at 4–6 weeks; lower-quality evidence than topical NSAIDs

Time to effect

4–6 weeks of consistent daily use

Best fit

Adults with knee or hand osteoarthritis seeking a non-systemic topical option

Less likely

Adults with severe OA needing systemic analgesia or joint replacement

Bottom line: A modest add-on for localised OA pain. Topical NSAIDs (diclofenac) have stronger evidence; capsaicin is an option when NSAIDs aren't tolerated.

SourceNCCIH Capsicum Fact Sheet — NCCIH MSKCC About Herbs — Capsicum — Memorial Sloan Kettering Cancer Center

Oral capsaicinoids — energy intake, thermogenesis, weight

Supplement benefit

Limited Evidence

Whiting 2014 meta-analysis of 20 trials found pre-meal capsaicinoids ≥2 mg modestly reduced subsequent ad libitum energy intake (~74 kcal/meal pooled). Thermogenic effect adds ~50 kcal/day net. Real but small effects; over weeks/months they translate to modest weight changes only when combined with sustained dietary effort. Many trials use 'non-pungent' encapsulated extracts (Capsimax-class) to allow blinding and avoid GI burn.

Effect size

≈74 kcal reduction in subsequent meal energy intake; ≈50 kcal/day thermogenic effect; modest cumulative weight outcome

Time to effect

Per-meal effects within hours; cumulative weight outcomes over weeks at best

Best fit

Adults using oral capsaicinoids as a modest adjunct to broader weight-management efforts

Less likely

Anyone expecting capsaicinoid pills to drive meaningful weight loss alone

Bottom line: A small, real metabolic nudge. Don't expect it to substitute for caloric deficit and exercise.

SourceWhiting et al., 2014 (meta-analysis) — PubMed — Appetite

Cardiovascular biomarkers (oral)

Biomarker support

Mixed Evidence

Observational and small interventional studies have explored capsaicin's effects on blood pressure, lipid profiles, and endothelial function. Effects are inconsistent and small. The mechanistic case (TRPV1 → improved endothelial NO signalling) is plausible but clinical evidence is preliminary. Don't take capsaicinoids primarily for cardiovascular risk reduction.

Effect size

Inconsistent small effects on BP and lipids; no hard-endpoint data

Time to effect

Not reliably established

Best fit

Adults using capsaicinoids for other reasons who might get a small cardiovascular nudge

Less likely

Adults seeking pharmacologic-level cardiovascular benefits

Bottom line: Statins, antihypertensives, and Mediterranean-diet patterns have dramatically stronger cardiovascular evidence.

SourceNCCIH Capsicum Fact Sheet — NCCIH

Functional dyspepsia / gastric tolerance

Supplement benefit

Mixed Evidence

Some small trials have explored chronic low-dose oral capsaicin for functional dyspepsia, proposing TRPV1 desensitisation in gastric afferents. Results are mixed; some patients tolerate it poorly. There is no clear case for capsaicinoid supplementation to treat dyspepsia. People with established GERD or ulcers should avoid high-dose oral capsaicinoids.

Effect size

Inconsistent — some patients improve, others worsen

Time to effect

Not reliably established

Best fit

None established

Less likely

Anyone with active gastritis, ulcer, or GERD

Bottom line: Skip for GI symptom treatment. Discuss dyspepsia management with a clinician.

SourceMSKCC About Herbs — Capsicum — Memorial Sloan Kettering Cancer Center

How it works

Capsaicinoids activate TRPV1, a heat-sensing ion channel on sensory neurons, generating the perception of heat and pain. Repeated exposure depletes substance P from nerve endings, the basis for topical capsaicin in pain management. Orally, capsaicinoids activate TRPV1 in the gut and stimulate sympathetic nervous system activity, contributing to small increases in resting energy expenditure and short-term satiety.

How to take it

1. Typical dose

• TOPICAL cream (0.025% or 0.075%): apply 3–4×/day to affected area for 6+ weeks • TOPICAL 8% patch (Qutenza): clinic-only single 30–60 min application; repeat every 3 months • ORAL capsaicinoid extract (encapsulated, non-pungent): 2–10 mg total capsaicinoids/day, often 30–60 min before meals • Dietary chili: a few teaspoons of chili sauce or cayenne per day delivers 2–10 mg capsaicinoids

2. Higher studied dose

Topical: 8% patch is the highest single-application dose. Oral: trials have used up to ~10 mg capsaicinoids/day; higher doses cause GI burn without clear additional benefit.

3. Timing

Topical: applied after washing hands, with no eye contact afterwards (wear gloves or wash hands immediately). Oral capsaicinoids for energy intake / thermogenesis: take 30–60 min before a meal.

4. With food

Oral: with or before food. Non-pungent encapsulated forms are gentler regardless.

5. Split dosing

Topical: applied as a thin film 3–4×/day for low-concentration creams. Oral: split across 2–3 doses before meals if going to the upper range.

6. How long to try

Topical low-concentration cream: 6+ weeks of consistent use for steady-state pain effect. 8% patch: every 3 months. Oral capsaicinoid supplements: 8–12 weeks to assess any weight/satiety benefit.

What to track

Pain scale (0–10) at 2, 4, and 6 weeks if using topical for chronic pain

Tolerance of the initial burning sensation (improves with consistent use)

Stomach / lower-GI burn if using oral supplements at higher doses

Body weight, waist circumference, and dietary adherence if oral use is for weight management

Bottom line: Topical capsaicin has the strongest evidence and the most distinctive use case. Oral capsaicinoids are a modest metabolic nudge, not a weight-loss drug.

5 commercial forms

Compare the main delivery options and what they’re best suited for.

Topical capsaicin cream (0.025% / 0.075%)

OTC pain cream

Over-the-counter creams applied 3–4×/day for 6+ weeks before steady-state pain relief. Burning sensation universal initially; improves with consistent use. Suitable for localised osteoarthritis, mild neuropathic pain.

Negligible systemic absorption; acts locally.

Topical capsaicin 8% patch (Qutenza)

Prescription / clinic

Single 30–60 minute clinic application provides weeks to months of relief in postherpetic neuralgia and painful peripheral neuropathy. Requires clinic supervision because of intense initial discomfort. The strongest topical evidence (Cochrane).

Local effect; minimal systemic absorption from short application.

Capsimax / non-pungent encapsulated capsaicinoids (oral)

GI-friendly oral

Encapsulated capsaicinoid extracts designed to release in the small intestine, avoiding oral and gastric burn. Used in most modern thermogenesis / appetite trials. Typical dose 2–6 mg total capsaicinoids/day.

Designed for distal-GI release; better tolerated than raw cayenne capsules.

Cayenne pepper capsules (oral)

Traditional

Standardised cayenne powder in capsule form. More likely to cause heartburn, oral burn, and lower-GI burn than non-pungent encapsulated forms. Variable capsaicinoid content per capsule.

Standard oral; GI tolerance is the practical limit.

Dietary chili / hot sauce

Food source

A few teaspoons of hot sauce or fresh chili can deliver 2–10 mg capsaicinoids — comparable to supplement doses. If you can tolerate the heat, dietary chili is a no-cost source.

Same molecule, same effect; tolerance depends on personal habituation.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

topical: burning, stinging, redness at application site (improves with repeated use)oral: heartburn / oral burn / lower-GI burn at higher intakesoccasional sneezing / coughing if cream is applied near nose/mouth

Serious risks

Eye contact with topical capsaicin causes severe burning — rinse with copious water and milk (casein binds capsaicinoids). Wash hands thoroughly after every topical application or wear gloves.
SourceNCCIH Capsicum Fact Sheet — NCCIH
Acute coronary symptoms have been reported (rare) when the 8% patch is applied to large skin areas — patches are applied in clinic and patients monitored.
SourceMou et al., 2013 (Cochrane) — PubMed — Cochrane Database of Systematic Reviews
Oral capsaicinoids can exacerbate active gastric or duodenal ulcer, hemorrhoids, anal fissures, or IBD flares.
SourceMSKCC About Herbs — Capsicum — Memorial Sloan Kettering Cancer Center

Who should avoid it

People with broken skin or active dermatitis at the topical application site — avoid until skin heals.
SourceNCCIH Capsicum Fact Sheet — NCCIH
People with severe hemorrhoids, anal fissures, or IBD flares — avoid high-dose oral capsaicinoids.
SourceMSKCC About Herbs — Capsicum — Memorial Sloan Kettering Cancer Center
People with active peptic ulcer or severe GERD — avoid high-dose oral capsaicinoids until controlled.
SourceMSKCC About Herbs — Capsicum — Memorial Sloan Kettering Cancer Center
Children under 18 for the 8% patch — safety not established for pediatric use.
SourceNCCIH Capsicum Fact Sheet — NCCIH
Pregnant or breastfeeding women considering oral capsaicinoid supplements — dietary chili is fine, supplemental doses are not well studied.
SourceNCCIH Capsicum Fact Sheet — NCCIH

Pregnancy & breastfeeding

Dietary chili / capsicum in cooking is generally considered safe in pregnancy at usual culinary amounts. Concentrated oral capsaicinoid supplements (Capsimax-class) have not been formally studied in pregnancy and should be avoided. Topical capsaicin has minimal systemic absorption, but discuss any chronic use with your obstetric provider; the 8% patch is generally avoided in pregnancy.

SourceNCCIH Capsicum Fact Sheet — NCCIH

Bottom line: Topical capsaicin is safe with sensible precautions (eye protection, broken skin). Oral capsaicinoid supplements: GI tolerance is the main practical limit.

Interactions

ACE inhibitors (lisinopril, enalapril, ramipril)Minor

Topical capsaicin has been linked to cough exacerbation in ACE-inhibitor users (ACEis can independently cause cough). Possibly additive if both present.

SourceNCCIH Capsicum Fact Sheet — NCCIH

anticoagulants / antiplatelet drugsMinor

Mild theoretical antiplatelet effect from capsaicinoids; rarely clinically meaningful at supplemental doses.

antihypertensivesMinor

Acute capsaicinoid intake can transiently affect blood pressure; usually inconsequential at typical intakes.

MAO inhibitorsMinor

Theoretical interaction with tyramine pathways; mostly relevant at very high dietary intakes.

Food sources

Food	Amount	%DV
Habanero / Scotch bonnet chili (fresh)	1 small chili (~3–8 mg capsaicinoids)	—
Cayenne pepper (ground)	1 tsp (~3–10 mg capsaicinoids, varies)	—
Jalapeño pepper (fresh)	1 medium (~0.5–1 mg capsaicinoids)	—
Hot sauce (Tabasco-class)	1 tsp (~0.5–2 mg capsaicinoids)	—
Sriracha-style chili sauce	1 Tbsp (~1–3 mg capsaicinoids)	—
Sweet bell pepper (red/yellow)	1 cup (negligible capsaicinoids — non-pungent variety)	—

Habanero / Scotch bonnet chili (fresh)

Amount: 1 small chili (~3–8 mg capsaicinoids)
%DV: —

Cayenne pepper (ground)

Amount: 1 tsp (~3–10 mg capsaicinoids, varies)
%DV: —

Jalapeño pepper (fresh)

Amount: 1 medium (~0.5–1 mg capsaicinoids)
%DV: —

Hot sauce (Tabasco-class)

Amount: 1 tsp (~0.5–2 mg capsaicinoids)
%DV: —

Sriracha-style chili sauce

Amount: 1 Tbsp (~1–3 mg capsaicinoids)
%DV: —

Sweet bell pepper (red/yellow)

Amount: 1 cup (negligible capsaicinoids — non-pungent variety)
%DV: —

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

TOPICAL: capsaicin concentration clearly stated (0.025% / 0.075% / 8%)

TOPICAL: cream / gel / lotion vehicle disclosed; fragrance-free preferred for sensitive skin

ORAL: total capsaicinoid content per serving clearly stated in mg

ORAL: 'non-pungent' encapsulated extract (e.g. Capsimax / OmniLean / Capsifen) if GI tolerance is a concern

Third-party tested (USP, NSF, ConsumerLab)

Avoid: high-dose 'fat burner' combo products that bury capsaicinoids inside proprietary blends

Be skeptical of…

'Burns fat fast' — net thermogenic effect is ~50 kcal/day; the weight outcome over weeks is modest at best

'Boosts metabolism by 25%' — total daily energy expenditure rises by a few percent at most

'Cures chronic pain' for topical use — Cochrane data show ≥30% relief in ~1 of 10 treated patients (NNT 10–12), not universal cure

Combination 'thermogenic' or 'metabolism support' products without disclosed capsaicinoid dose

Mega-dose oral capsicum products marketed for daily use without GI-tolerance guidance

Frequently asked questions

Will capsaicinoids burn fat?⌄

Effects on metabolism are real but small; meaningful weight loss requires diet and exercise.

References by claim

Topical pain — postherpetic neuralgia / peripheral neuropathy (8% patch)

Mou et al., 2013 (Cochrane) — PubMed — Cochrane Database of Systematic Reviews (2013) link

Oral capsaicinoids — energy intake, thermogenesis, weight

Whiting et al., 2014 (meta-analysis) — PubMed — Appetite (2014) link

Topical osteoarthritis pain (adjunct)

NCCIH Capsicum Fact Sheet — NCCIH (2024) link

MSKCC About Herbs — Capsicum — Memorial Sloan Kettering Cancer Center (2024) link

Other references

Hayman & Kam, 2008 (pharmacology review) — PubMed — Current Anaesthesia & Critical Care (2008) link

Track Capsaicinoids with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.